KAMLESH DAVE: Open Payments
NPI 1679599500 · LAGRANGE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$618 in 33 payments from 9 companies in 2025. Trend: 2023 $694 · 2024 $667 · 2025 $618
Food & beverage: $618
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 9 | $166 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 8 | $152 |
| Amgen Inc. | 4 | $68 |
| GlaxoSmithKline, LLC. | 3 | $54 |
| Axsome Therapeutics, Inc. | 2 | $53 |
| AstraZeneca Pharmaceuticals LP | 3 | $46 |
| ABBVIE INC. | 2 | $45 |
| Exact Sciences Corporation | 1 | $20 |
| Otsuka America Pharmaceutical, Inc. | 1 | $14 |
Products named: CAPLYTA, HETLIOZ, TRELEGY ELLIPTA, OTEZLA, Auvelity, AIRSUPRA, VRAYLAR, FANAPT.
Industry payments across KY — which companies pay providers there.
